Pinterest (NYSE:PINS) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Speaker3Good evening. Thank you for attending today's Pinterest's fourth quarter and full year 2025 earnings call. My name is Megan, and I'll be your moderator for today. All lines will be muted during the presentation portion of the call, with an opportunity for questions and answers at the end. If you would like to ask a question during that time, simply press star one on your telephone keypad. We do ask that you limit yourselves to ...

Arista Networks (NYSE:ANET) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Speaker14Welcome to the fourth quarter and 2025 Arista Networks financial results earnings conference call. During the call, all participants will be in a listen-only mode. After the presentation, we will conduct a question-and-answer session. Instructions will be provided at that time. If you need to reach an operator at any time during the conference, please press the star key followed by zero. As a reminder, this conference i ...

Applied Materials (NasdaqGS:AMAT) Q1 2026 Earnings call February 12, 2026 04:30 PM ET Speaker11Welcome to the Applied Materials first quarter of fiscal 2026 earnings call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will invite... You will be invited to participate in a question-and-answer session. I would now like to turn the call over to Mike Sullivan, Corporate Vice President of Investor Relations. Please go ahead.Speaker10Good afternoon, everyone, and thank yo ...

Financial Data and Key Metrics Changes - Total revenue for Q1 2026 was $3.9 million, up from $3.8 million in the prior year period [13] - Subscription revenue was $3.2 million, compared to $3.0 million in the prior year, representing 81% of total revenue [13] - Services revenue increased to $758,000 from $743,000 in the prior year [14] - Gross profit was $2.6 million, an increase from $2.5 million in the prior year, with a gross profit margin of 66% [14] - Net loss narrowed to $100,000 from a loss of $600,000 in the prior year, with positive adjusted EBITDA of $122,000 compared to negative $193,000 previously [16] Business Line Data and Key Metrics Changes - Core products accounted for 60% of total revenue, growing 17% to $2.4 million from $2.0 million last quarter [6] - HawkSearch represented 63% of subscription revenue, generating $2 million, up from $1.9 million last quarter [6] - Average ARR per customer increased by 12% to $28,000 from $25,000 last quarter [7] - Average subscription per customer rose to $33,000 from $30,000 last quarter [7] Market Data and Key Metrics Changes - New customer acquisition continued to grow, with 13 new licenses sold, totaling $1.2 million in contract value [7] - More than half of new license sales included AI products, indicating strong demand for AI capabilities [8] - HawkSearch was ranked number 1 in Gartner's 2025 Critical Capabilities Report, highlighting its competitive position in the market [9] Company Strategy and Development Direction - The company aims for HawkSearch and core products to exceed 70% of overall revenue this year, driving faster, more profitable growth [12] - Continued focus on product innovation, customer success, and delivering shareholder value is emphasized [18] - The company is targeting B2B manufacturing and distribution markets, which are seen as rapidly maturing with technology adoption [55] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth, with expectations for HawkSearch growth to reach 20% this year [51] - The total addressable market remains unchanged, with increased adoption of AI products among existing customers [42] - The company is differentiating itself through analytics and a data lake that enhances AI capabilities for customers [49] Other Important Information - Cash at the end of Q1 2026 was $1.5 million, with total assets of $15.7 million and liabilities of $6.2 million [16][17] - The company has no significant debt or contingent payments remaining from previous transactions [16] Q&A Session Summary Question: Clarification on ARR figures - Management confirmed that the average ARR per new customer is $28,000, up from $25,000, and overall revenue per customer is now $33,000, up from $30,000 last quarter [23][34] Question: Impact of increasing package prices on customer acquisition - Management stated that the total addressable market has not changed, and customers are now more willing to invest in AI add-ons [42][46] Question: Competitive landscape changes - Management noted that top competitors remain the same, but differentiation is achieved through advanced analytics and AI capabilities [48][49] Question: Future growth expectations for ARR - Management expects continued growth in ARR, supported by a solid pipeline of new customers and opportunities for add-on sales [52][54] Question: Marketing spend effectiveness - Management indicated that marketing dollars are being spent effectively, with plans to increase investment in successful campaigns [61][64] Question: Stability of gross margins - Management expects gross margins to remain stable in the mid-60s range, with subscription margins around 70% and service margins in the low 50s [66][74]

Vertex Pharmaceuticals (NasdaqGS:VRTX) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Speaker9Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2025 earnings call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Ms. ...

Financial Data and Key Metrics Changes - Fourth quarter revenue reached $122 million, a 30% increase year-over-year, with 40% from systems and 60% from recurring revenue [5][10] - Full year revenue for 2025 was $453 million, up 13% year-over-year, indicating a market recovery trajectory [5][10] - Gross margin for Q4 was 40.8%, lower than guidance due to one-time inventory charges [11] - Cash and investments increased by $286 million during Q4, totaling $484 million at year-end [12] Business Line Data and Key Metrics Changes - Recurring business represented about 60% of total revenue in Q4, with recurring bookings up 34% sequentially [4][5] - Systems demand increased by 47% quarter-over-quarter, driven by higher equipment orders from major global customers [4][5] - Recurring revenue grew 4% quarter-over-quarter and 25% year-over-year, reflecting strong customer reliance [5] Market Data and Key Metrics Changes - Test serialization trends improved, with overall utilization reaching 76% by the end of December, with computing at 78% and automotive at 75% [6][9] - The top ten customers accounted for approximately 63% of Q4 bookings, indicating healthy diversification [5] Company Strategy and Development Direction - The company is focusing on high-performance computing, HBM memory, and AI-related high-growth opportunities [11][12] - A strategic convertible notes offering was completed, raising gross proceeds of $287.5 million to strengthen the balance sheet and support strategic initiatives [12][14] - The company aims to support R&D investments enabling design wins in compute markets, including AI data center infrastructure [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating regional shifts while aligning with customers investing in long-term technology transitions [9] - The outlook for Q1 2026 anticipates seasonally flat revenue with recurring revenue expected to represent about 60% of total revenue [15] - Management noted an increase in customer engagement and design win traction, entering 2026 with positive momentum [10][16] Other Important Information - The company secured multiple design wins across various sectors, including automotive ADAS and AI device testing [8][9] - The company has a balanced mix of recurring and system revenue, which is expected to support growth in 2026 [10] Q&A Session Summary Question: Order activity in Q4 - Management noted systems orders were up 47% quarter-over-quarter, with recurring orders up 34% [19][20] Question: Revenue from Neon high bandwidth memory - The company exited 2025 with $11 million in HBM revenue and forecasts $15 million to $20 million for 2026 [22][23] Question: Eclipse activity and capacity - The company confirmed it has the capacity to meet demand for the Eclipse handler, with production ramping expected in the second quarter [25][26] Question: Customer activity changes - Management observed increased demand from traditional customers and strong pull for the Eclipse product line in compute and mobile applications [33] Question: IDM versus OSAT performance - Utilization rates for IDMs were slightly higher than OSATs in Q4, with expectations that OSATs may see faster growth in Q1 [46][47]

Artivion (NYSE:AORT) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Speaker3Good afternoon, and welcome to the Artivion fourth quarter and year-end 2025 earnings call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference o ...

Financial Data and Key Metrics Changes - 10x Genomics reported $166 million in revenue for Q4 2025, representing a 1% increase year-over-year and exceeding the high end of guidance [18] - Full-year revenue for 2025 was $599 million, excluding $44 million from patent litigation settlements [4] - Gross margin improved to 68% in Q4 2025 from 67% in the prior year, driven by lower inventory write-downs and costs [20] - Operating expenses decreased by 18% in Q4 2025, reflecting cost discipline and efficiency [21] - Cash balance increased by $130 million year-over-year, ending 2025 with $523 million [21] Business Line Data and Key Metrics Changes - Total consumables revenue grew by 6%, with single-cell consumables revenue up 3% and spatial consumables revenue up 14% [19] - Single-cell consumables volumes grew at a double-digit rate each quarter, driven by the adoption of lower-cost products like FLEX [5] - Spatial consumables revenue growth was primarily driven by the success of the Xenium platform [6] Market Data and Key Metrics Changes - Revenue from the Americas declined by 6%, while EMEA and APAC regions grew by 7% and 9%, respectively [20] - The operating environment remained challenging, particularly in the U.S. academic and government funding sectors, impacting customer purchasing decisions [4][20] Company Strategy and Development Direction - The company is focused on continuous innovation and expanding its product offerings, particularly in single-cell and spatial technologies [10] - 10x Genomics aims to leverage advancements in AI and biology measurement technologies to drive growth [11] - The company is pursuing clinical applications for diagnostics, collaborating with academic medical centers to generate clinical evidence [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's position amidst ongoing funding challenges, noting a gradual improvement in customer sentiment [27] - The outlook for 2026 includes revenue guidance of $600 million to $625 million, reflecting expectations of continued growth in single-cell and spatial consumables [22] - Management acknowledged the systemic turbulence in research funding dynamics but noted recent NIH budget approvals as a positive sign [22] Other Important Information - The company launched several new products in 2025, including the FLEX APEX assay, which has been well-received by customers [8] - The company is seeing strong demand for its Xenium platform, which is expected to continue driving growth in spatial analysis [10] Q&A Session Summary Question: Can you comment on ordering patterns and expectations for academic and pharma? - Management noted that the environment remains steady but cautious, with ongoing uncertainty in academic funding impacting purchasing decisions [27] Question: How did volume growth and pricing impact single-cell consumables? - Management indicated that while volume growth was strong, pricing dynamics are complex, with various factors influencing the overall revenue guidance for 2026 [31][35] Question: What are the expectations for clinical translational space? - Management highlighted a hybrid strategy to enable clinical evidence generation while also pursuing direct clinical applications [48][50] Question: How is the company addressing competitive dynamics? - Management expressed confidence in their competitive position, citing continuous innovation and strong customer sentiment for their products [76] Question: What is the outlook for the Visium platform? - Management acknowledged that while Visium did not grow in 2025, they will continue to support its applications while focusing on the growth of the Xenium platform [80]

Q4 2025 Investor Presentation Tucows Inc. Q4 2025 Investor Update NASDAQ TCX | TSX TC Safe harbor statement This presentation may contain forward-looking statements, relating to the Company's operations or to the environment in which it operates, which are based on Tucows Inc.'s operations, estimates, forecasts and projections. These statements are not guarantees of future performance and are subject to important risks, uncertainties and assumptions concerning future conditions that may ultimately prove to ...

Financial Data and Key Metrics Changes - Net sales increased by 11% year-over-year, with a price mix contributing 70 basis points to this growth, while volume declined by 2.2% due to pressures in certain product lines [16][17] - Gross margin as a percentage of sales decreased by 30 basis points to 48.5%, influenced by increased outside purchases related to the Simple Mills business model [17] - GAAP diluted EPS for the quarter was a loss of $0.32, a decrease of $0.52 from the prior year, primarily due to a $136 million non-cash impairment of intangible assets [18][19] Business Line Data and Key Metrics Changes - The fresh packaged bread category saw Flowers maintain unit share, with Dave's Killer Bread gaining 20 basis points, while traditional loaf unit sales declined by 4% in Q4 [3][4] - The cake business experienced a 5% growth in unit sales, driven by the strength of the Wonder brand, despite a 3% decline in category unit sales [11] - Specialty premium loaf gained 60 basis points of unit share, largely driven by DKB, which added 50 basis points [10] Market Data and Key Metrics Changes - The overall bread category experienced a 2% decline, while the food category saw a modest increase in unit sales [4] - The competitive environment remained rational but challenging, with the average price per unit in the bread category rising by 1.1% [26] - Consumer behavior is shifting towards value-seeking, with increased sales in club stores and a decline in center store volumes [28][29] Company Strategy and Development Direction - The company is conducting a comprehensive review of operations to reignite top-line growth and expand margins, focusing on optimizing the brand portfolio and enhancing supply chain capabilities [4][5] - Investments in marketing and innovation are expected to create near-term margin pressure but are deemed essential for long-term growth [5][22] - The integration of Simple Mills is progressing well, with expectations for significant growth driven by innovation and expanded distribution [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for 2026, anticipating continued category headwinds, particularly in traditional loaf, and inflationary pressures on inputs [21][22] - The company plans to balance investments in leading brands with the need to manage costs and maintain profitability [22][30] - Management remains committed to navigating current challenges while positioning for future success through strategic initiatives [30] Other Important Information - The company generated cash flow from operating activities of $446 million in 2025, an increase of $34 million over the prior year [20] - Capital expenditures decreased to $127 million, while dividends paid increased to $209 million [20] - The company is focused on maintaining a strong balance sheet, with net debt to trailing 12-month adjusted EBITDA at approximately 3.3x [20] Q&A Session Summary Question: What are the expectations for 2026? - The company expects total sales to be down 180 basis points to up 20 basis points, with category headwinds anticipated to be around 4% [21] Question: How is the Simple Mills integration progressing? - The integration is progressing well, with expectations for double-digit sales growth driven by innovation and expanded distribution [24]